The business case for Decree 2026-288 period underwear: A buyer’s guide
The urgent procurement timeline for Decree 2026-288’s October launch
“I have worked alongside laboratories, regulators and brand teams across the reusable absorbent hygiene category for more than a decade, including creating a new working absorbency testing protocol for reusable AHPs that has been adopted by international standards laboratory Intertek, and personally leading performance testing on more than 200 products. Most of the supplier failures I have seen in that time could have been spotted long before contract signing if the right four questions had been asked. I’m sharing that framework here so you can benefit from this as you navigate your way through the complexity of procurement.”
Outline
The five risks of choosing the wrong supplier for the French period equity scheme
The four-filter supplier evaluation framework:
- Filter 1: Compliance certifications you must verify in document form
- Filter 2: Independent performance verification you must demand
- Filter 3: Manufacturing scale and credible lead-time evidence
- Filter 4: Economics that hold the €19 retail cap
The red flags that should disqualify a supplier
Where the next stage of work begins
Key takeaways
Most apparel manufacturers pitching to supply period underwear for Decree 2026-288 will fail at least one of four critical filters: compliance, performance, scale or economics. The right evaluation framework filters them out before contract signing – rather than after launch failure.
- Wrong supplier selection compounds across five independent risks
- ‘In progress’ certifications will not unlock LPP reimbursement coding
- Demand independent verification from internationally accredited laboratories
- In-house performance claims are insufficient brand protection
- National volumes demand automated production
- Landed cost must protect the pharmacy retail margin
- Lead times that can't land stock during in time for launch are disqualifying
- Filter rigorously before contract, not after launch failure
An introduction
A purchasing manager or category buyer who selects the wrong supplier for the French menstrual equity and waste reduction scheme could face five compounding consequences playing out across a 12-to-24-month window with no easy exit.
- They might miss the launch date and initial rush of publicity and purchasers
- They might not be granted the LPP code that denotes eligibility for reimbursement
- Their national volumes might fail to materialise
- The product might damage the reputation of their brand through leakage or a PFAS finding
- The unit economics might fail to hold the required pharmacy and distributor margins
The five risks of choosing the wrong period underwear supplier
Each of these risks is independent. A supplier that fails on any one of them can sink the launch. A supplier that fails on two or more is a category-level failure waiting to happen.
The five risks are: missing the 1 October 2026 launch date, certification gaps blocking LPP code issuance, inability to supply network-scale volumes, product performance failures damaging the brand, and unit economics that cannot hold the €19 retail price cap without compressing margins.
A defensible procurement process screens for all five at the supplier evaluation stage:
Filter 1: Compliance – verify certifications held, not promised
The final product specifications were published in August 2026 following industry consultation. They require manufacturers to demonstrate compliance with certain social and environmental standards, such as GOTS certification, and hold OEKO-TEX Standard 100 Class II certification for the entire garment (this is the relevant product class for skin-contact textiles such as menstrual underwear). Any part of the underwear that comes into contact with skin when worn must be made from either lyocell or GOTS Organic-certified cotton (or equivalent), with up to 5% elastane permitted for stretch.
Bonus certifications for your peace of mind might include ISO 13485 for medical device quality management systems and the CE Mark covering medical device classification.
Demand to see the manufacturer’s certificates, dated and current, with the certifying body identifiable – not letters of intent or pending applications.
A supplier whose certifications are described as ‘in progress’ or ‘under audit’ is a supplier whose product will not have an LPP code issued in time for the October launch. The decree application dossier requires the certifications as supporting evidence. Without them, the LPP code does not issue, and without a code the product cannot be referenced by the pharmacy ordering system.
Filter 2: Performance – demand independent verification
The reusable period product category has a poor track record on performance and chemical-safety claims. PFAS class actions in the United States have specifically targeted brands whose marketing claims were contradicted by independent testing. The legal and reputational exposure is real.
The final product specifications applicable to French Decree 2026-288 reimbursement specify that companies manufacturing for the scheme need to verify that their underwear retains its absorbency and durability after 52 wash cycles.
In-house testing is not enough. The specifications explicitly say that all testing must be carried out by an independent European laboratory certified ISO/IEC 17025.
Recognised names in this space include Intertek, SGS and Eurofins. For your own peace of mind, also ask your manufacturer for evidence that your product has been independently tested for working absorbency under bodyweight pressure, liquid acquisition rate, leakproof performance across the claimed wear duration (typically 8 to 12 hours), wash durability after a stated minimum number of wash cycles, and explicit PFAS testing returning ‘not detected’ on an OEKO-TEX Standard 100 Class II certified report.
In line with the EU’s Empowering Consumers for the Green Transition Directive (EmpCo) anti-greenwashing regulations, which become applicable from 27 September 2026, you should also require that potential manufacturers provide independent fibre analysis testing results to back up any claims regarding fibre composition (for example organic cotton).
A supplier offering performance or composition claims without third-party laboratory reports, on letterhead, naming the test method, is a brand risk you should not accept onto your shortlist.
Filter 3: Scale – capacity and lead-time evidence for network volumes
Conservative predictions estimate increased demand for about three million pairs of period underwear in year one. That is regulated hygiene volume, not fashion volume, and it places very different demands on a production line.
Apparel and lingerie manufacturers relying on manual-labour production lines are simply not set up to produce these quantities. Only a specialist manufacturer with proven automated manufacturing processes already online and ready to go will be able to produce the required volumes in time to meet the launch-date deadline.
Demand evidence of historical production runs at comparable scale, evidence of automated manufacturing capability (manual textile production at this volume leads to quality drift without the consistency required), evidence of vertically integrated quality control rather than outsourced quality assurance bolted onto a third-party factory, and a credible lead-time schedule that lands launch stock in your distribution network in time for the October launch. A supplier who cannot produce this evidence is offering you no buffer for the inevitable logistics, customs or wholesaler reception issues that come with any new product introduction.
Filter 4: Economics – cost-of-goods reality check at the €19 retail price cap
Request a fully loaded cost breakdown showing how the supplier’s landed unit cost in France allows you to hold the €19 retail cap, standard pharmacy retail margins and your distributor or wholesaler margin.
If the numbers do not work on the page now, they will not work after contract signing either. Trying to negotiate cost down with a supplier whose underlying cost base is structurally too high typically results in compliance corners being cut, raw material substitutions being made or quality drifting between sample and production batch.
The economics filter is the one most often skipped because the supplier pitch focuses on unit price rather than landed cost. Insist on the full picture.
Supplier red flags – when to remove a manufacturer from your shortlist
Any one of these is grounds to remove a supplier from your shortlist:
- Certifications listed as ‘in application’ rather than held
- Refusal or inability to provide independent third-party test reports
- Inability to evidence prior production at network scale
- Manual textile production lines pitched for a regulated absorbent hygiene category
- Landed cost that requires you to compress pharmacy margins
- Lead times that can’t deliver stock in time for the October 2026 launch
- Any vagueness around PFAS testing or top-sheet material composition
- Reluctance to provide a fully loaded landed cost breakdown
You will rarely find a supplier who clears every filter. That’s the point of the framework – the shortlist you are looking for is short.
Next steps
Once you have filtered your shortlist down to suppliers who can demonstrate compliance, independent performance verification, manufacturing scale and viable economics inside the €19 cap, your work shifts to implementation. The next article in this series sets out an accelerated implementation playbook covering parallel execution across LPP code registration, product evaluation, ROI modelling tailored to your network, packaging design and planogram approval. It also introduces a specialist reusable absorbent hygiene manufacturing partner whose operating model is geared up to meet the requirements of the French reimbursement scheme.
Read more on this topic in this five-blog series
About the author
Frantisek Riha-Scott, Founder and CEO, Confitex Technology
As the tech leader in reusable personal hygiene since 2013, Confitex designs and manufactures award-winning washable period and incontinence products for leading retail, pharmacy and healthcare brands worldwide. Frantisek has spent more than a decade working at the intersection of fashion design, textile engineering and absorbent hygiene manufacturing, and has worked directly with independent laboratories to shape emerging industry performance standards for reusable absorbent hygiene. His perspective on the French menstrual equity and waste reduction scheme is grounded in detailed working knowledge of the certifications required to trade under Decree 2026-288 and in active conversations with organisations preparing for the October 2026 launch. He writes to help pharmacy category managers, hygiene buyers, purchasing directors and procurement leaders cut through the regulatory complexity and make supplier decisions with confidence. Connect with Frantisek on LinkedIn.
